跳转至内容
Merck
所有图片(1)

主要文件

G1007465

HPLC Analysis of Alfuzosin and Related Substances on Chromolith® HighResolution RP-18 endcapped

application for HPLC

登录查看公司和协议定价
所有图片(1)

About This Item

技术

HPLC: suitable

试验参数

sample preparation: Dissolve 40.0 mg of the sample in 100 mL of mobile phase. 0.4 mg/mL (400 ppm) of USP Alfuzosin System Suitability Mixture RS in Mobile phase
column: Chromolith® HighResolution RP-18 endcapped, 150 x 4.6 mm (1.52023.0001)
mobile phase: [A] 5 ml of perchloric acid in 900 mL Milli-Q water. Adjust pH to 3.5 with 2M NaOH. Diluter to 1000 mL with water; [B] acetonitrile; [C] THF; (80:20:1, A:B:C)
flow rate: 1 mL/min
pressure: 994 psi (69 Bar)
column temp.: 25 °C
detector: 254 nm cell: 10 μL
injection: 10 μL
sample: 0.40 μg/mL of Alfuzosin Hydrochloride in Mobile phase from the Sample solution

适用性

application for HPLC

应用

pharmaceutical (small molecule)

法律信息

Chromolith is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

说明
    Deacylated Alfuzosin
    Alfuzosin
    Furamide analog

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持